Guest post: Why the fuss over Quindell and Slater & Gordon?

OK, the headline is clickbait – kind of. There does, of course, need to be an investigation into Quindell’s financial ‘restatements’, which it admitted earlier this month meant that the 2013 profit after tax of £83m should have been a loss of £68m, and net assets at 31 December 2013 should have been £446m, rather than £668m. That’s a seriously wonky piece of accounting.

Continue reading “Guest post: Why the fuss over Quindell and Slater & Gordon?”

Bryan Cave’s London head talks not being ‘all singing and all dancing’ as firm hires Macfarlanes structured finance chief in City push

After having carried out a strategic review which will see the Global 100 firm look to create three ‘best-in-class’ international practices, Bryan Cave has hired Macfarlanes‘ structured finance and capital markets chief Rachel Kelly as part of a drive to build its financial services offering in the City.

Continue reading “Bryan Cave’s London head talks not being ‘all singing and all dancing’ as firm hires Macfarlanes structured finance chief in City push”

Second edition: Freshfields, Linklaters and Macfarlanes advise on Pearson’s £469m sale of The Economist

Freshfields Bruckhaus Deringer has reprised its role for Pearson as, just weeks after selling the Financial Times, the publishing group agreed to sell its stake in The Economist group for £469m to Macfarlanes‘ client Exor and back to the group itself.

Continue reading “Second edition: Freshfields, Linklaters and Macfarlanes advise on Pearson’s £469m sale of The Economist”

Mintz Levin scales back London office as managing partner leaves to set up pharma boutique

Having lost the bulk of its City patent practice to fellow US firm Cooley earlier this month, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo has made the decision to scale back its London offering with managing partner Julian Crump exiting to establish his own pharmaceuticals boutique.

Continue reading “Mintz Levin scales back London office as managing partner leaves to set up pharma boutique”